National Kidney Foundation
@nkf
Followers
44K
Following
5K
Media
4K
Statuses
19K
We’re fighting to eliminate preventable kidney disease, accelerate innovation, and dismantle structural inequities in kidney care. Join our fight.
Joined July 2007
Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: https://t.co/lmIArrao9n
3
2
3
Join us virtually as we highlight real-world implementation data from NKF’s flagship CKDintercept program, a national strategy to improve CKD testing, diagnosis, and management in the primary care setting. RSVP: https://t.co/59uI1nTNyS
0
2
6
Today is #C3GAwarenessDay! C3G is a rare kidney disease with a lifelong impact. Explore our resources for understanding, diagnosing, and treating C3G.
kidney.org
C3G, or complement 3 glomerulopathy, is a rare kidney disease with a lifelong impact.
3
4
8
Patients with kidney disease deserve more than outdated technology and limited options. Let’s create better treatments and better outcomes.
4
5
13
“Fantasy Life i” NOW ON SALE! This is your other life! Enjoy an adventure that transcends time and space!
3
5
145
We are one community united by a shared belief in the lifesaving power of our collective steps. Will you contribute to our goal by walking with us? https://t.co/Mh7WWVP0Fg
#KidneyWalk
3
5
9
Jessika and Joey didn’t let kidney failure stop them from falling in love or planning a wedding at the Kidney Walk. Here’s how their NKF community helped make it happen.
kidney.org
Their engagement made headlines. Now they’re hoping he’ll be the match she needs to leave dialysis behind.
0
0
11
TODAY is Kidney Heroes Giving Day! Today we honor KIDNEY HEROES and the life-changing difference they make for people with kidney disease. From donors and recipients to doctors and family members, anyone can be a kidney hero. Honor your hero: https://t.co/8HU4q48Ii9
2
3
9
When Patrick experienced sudden foot pain, he never imagined it would lead to a diagnosis of IgA nephropathy, or IgAN, a serious form of chronic kidney disease.
kidney.org
Learn how Patrick faced 10 years of dialysis for IgA nephropathy, received a transplant, and now inspires other kidney patients to find hope and purpose.
0
1
5
Currently, there aren’t enough donated kidneys to meet the growing demand. But xenotransplantation could help change that.
kidney.org
This year, one of the most groundbreaking developments in kidney care is finally becoming reality: The FDA approved the first clinical trials for kidney xenotransplantation in the U.S. This moment...
1
4
11
If you know someone living with immunoglobulin A nephropathy (IgAN), or Berger’s disease, this clinical research study may be an option. Learn more: https://t.co/lmIArrao9n
0
0
2
Hiding your fungus damaged toenails? Get clear, healthy-looking nails with clinically proven NONYX!
0
4
33
Tell your legislator to support programs that work to increase early detection, improve outcomes, address health disparities, and develop innovative treatments for kidney patients. https://t.co/bMTt90Y5gQ
2
4
11
This clinical research study is evaluating an investigational treatment option to potentially help manage and slow the progression of immunoglobulin A nephropathy (IgAN), or Berger’s disease. Learn more: https://t.co/lmIArrao9n
1
2
4
RESET-SLE™ is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational cell therapy, CABA-201, in patients with active lupus nephritis (LN) or active lupus (SLE) without renal involvement. Learn more about the study at https://t.co/USs66KtCm0.
0
0
2
The RAINIER Study aims to reach higher summits in IgAN research. Learn more: https://t.co/jQlzIpeTt8
1
0
2
Futures Trader? Get 40% off + pay no activation fees. Copy trade up to 5 accounts, end-of-day drawdown in our live-market PRO+ accounts and still daily PRO payouts!
0
1
16
Today is #KidneyCancerAwarenessDay! Do you know the facts about kidney cancer? Watch our short animated videos to learn more.
2
4
12
Today is #FSGS Awareness Day! The New Era Act helps patients with rare kidney diseases by promoting early detection of rare and genetic kidney diseases, enhancing education of doctors and patients, and conducting more research. We need YOUR voice to push it across the finish
2
2
8
Patients living with Immunoglobulin A nephropathy (IgAN), or Berger’s disease, may be eligible for a clinical research study that may help improve kidney function and slow the progression of IgAN. Learn more: https://t.co/lmIArrao9n
0
3
5
RESET-SLE™ is a phase 1/2 clinical trial being conducted to evaluate the effects of an investigational cell therapy, CABA-201, in patients with active lupus nephritis (LN) or active lupus (SLE) without renal involvement. Learn more about the study at https://t.co/USs66KtCm0.
0
1
4
For 75 years, your voices, actions, and generosity have been critical to our success. Join us as we accelerate progress, drive innovation, and ensure kidney care is accessible to all. Take action: https://t.co/UysSOPqQHR
#NKF75years
0
0
1
AI feels weird right now. You don’t need another hype-fest — you need your people. Two days. 24 hours. 20+ speakers. Register FREE today
0
7
26
Home dialysis lets people manage treatment at home with peritoneal dialysis or home hemodialysis. Is it right for you? Take this quick quiz to find out.
kidney.org
Our guide for home dialysis patients and care partners, offering support on types, preparation, and nutrition, resources.
1
1
5